Cronos Pb Ratio vs Price To Sales Ratio Analysis

CRON Stock

CAD 2.79 0.08 2.95%

Cronos financial indicator trend analysis is way more than just evaluating Cronos Group prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cronos Group is a good investment. Please check the relationship between Cronos Pb Ratio and its Price To Sales Ratio accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Pb Ratio vs Price To Sales Ratio

Pb Ratio vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cronos Group Pb Ratio account and Price To Sales Ratio. At this time, the significance of the direction appears to have weak relationship.

The correlation between Cronos' Pb Ratio and Price To Sales Ratio is 0.37. Overlapping area represents the amount of variation of Pb Ratio that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of Cronos Group, assuming nothing else is changed. The correlation between historical values of Cronos' Pb Ratio and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Pb Ratio of Cronos Group are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Pb Ratio i.e., Cronos' Pb Ratio and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

0.37

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Pb Ratio

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Cronos Group stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Cronos sales, a figure that is much harder to manipulate than other Cronos Group multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Most indicators from Cronos' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cronos Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

As of the 23rd of December 2024, Selling General Administrative is likely to drop to about 43.8 M. In addition to that, Tax Provision is likely to grow to about (3.1 M)

Cronos fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Non Currrent Assets Other	Other Assets	Net Receivables	Good Will	Common Stock Total Equity
Total Assets		0.8	0.87	1.0	-0.99	0.99	0.93	1.0	0.97	1.0	0.9	0.87	0.93	0.76	0.88	1.0	0.43	0.81	0.98	0.84	0.87	0.64	0.8	0.77	0.75	0.88
Other Current Liab	0.8		0.98	0.76	-0.75	0.86	0.91	0.77	0.85	0.79	0.53	0.72	0.69	0.3	0.98	0.77	0.4	0.58	0.67	0.81	0.46	0.65	0.75	0.28	0.98	0.49
Total Current Liabilities	0.87	0.98		0.83	-0.84	0.91	0.96	0.84	0.9	0.86	0.64	0.76	0.78	0.45	1.0	0.85	0.39	0.65	0.76	0.84	0.61	0.67	0.73	0.43	0.95	0.63
Total Stockholder Equity	1.0	0.76	0.83		-0.99	0.98	0.9	1.0	0.96	1.0	0.92	0.86	0.93	0.79	0.84	1.0	0.42	0.82	0.99	0.82	0.89	0.63	0.79	0.81	0.71	0.9
Net Debt	-0.99	-0.75	-0.84	-0.99		-0.97	-0.91	-1.0	-0.95	-0.99	-0.9	-0.85	-0.92	-0.81	-0.84	-0.99	-0.37	-0.79	-0.98	-0.8	-0.91	-0.6	-0.77	-0.83	-0.7	-0.92
Retained Earnings	0.99	0.86	0.91	0.98	-0.97		0.94	0.98	0.98	0.98	0.82	0.88	0.89	0.67	0.92	0.98	0.39	0.77	0.94	0.84	0.81	0.66	0.85	0.69	0.83	0.82
Accounts Payable	0.93	0.91	0.96	0.9	-0.91	0.94		0.91	0.91	0.93	0.78	0.81	0.84	0.59	0.96	0.92	0.39	0.71	0.86	0.81	0.74	0.68	0.71	0.59	0.85	0.75
Cash	1.0	0.77	0.84	1.0	-1.0	0.98	0.91		0.96	1.0	0.9	0.85	0.92	0.77	0.85	1.0	0.39	0.79	0.98	0.8	0.88	0.62	0.8	0.79	0.72	0.89
Non Current Assets Total	0.97	0.85	0.9	0.96	-0.95	0.98	0.91	0.96		0.96	0.86	0.92	0.92	0.69	0.91	0.96	0.56	0.85	0.92	0.93	0.79	0.7	0.84	0.69	0.82	0.82
Cash And Short Term Investments	1.0	0.79	0.86	1.0	-0.99	0.98	0.93	1.0	0.96		0.89	0.84	0.92	0.76	0.86	1.0	0.38	0.79	0.98	0.8	0.88	0.62	0.78	0.78	0.73	0.89
Common Stock Shares Outstanding	0.9	0.53	0.64	0.92	-0.9	0.82	0.78	0.9	0.86	0.89		0.82	0.92	0.87	0.65	0.9	0.56	0.88	0.94	0.77	0.89	0.58	0.61	0.88	0.46	0.93
Non Current Liabilities Total	0.87	0.72	0.76	0.86	-0.85	0.88	0.81	0.85	0.92	0.84	0.82		0.85	0.59	0.78	0.84	0.69	0.85	0.82	0.87	0.68	0.69	0.88	0.64	0.69	0.73
Other Current Assets	0.93	0.69	0.78	0.93	-0.92	0.89	0.84	0.92	0.92	0.92	0.92	0.85		0.76	0.79	0.92	0.55	0.82	0.91	0.83	0.82	0.77	0.67	0.76	0.63	0.85
Other Stockholder Equity	0.76	0.3	0.45	0.79	-0.81	0.67	0.59	0.77	0.69	0.76	0.87	0.59	0.76		0.46	0.78	0.26	0.73	0.84	0.59	0.97	0.34	0.36	0.98	0.24	0.97
Total Liab	0.88	0.98	1.0	0.84	-0.84	0.92	0.96	0.85	0.91	0.86	0.65	0.78	0.79	0.46		0.86	0.41	0.66	0.77	0.85	0.61	0.68	0.74	0.44	0.95	0.64
Total Current Assets	1.0	0.77	0.85	1.0	-0.99	0.98	0.92	1.0	0.96	1.0	0.9	0.84	0.92	0.78	0.86		0.38	0.79	0.99	0.8	0.88	0.62	0.78	0.79	0.72	0.89
Short Long Term Debt Total	0.43	0.4	0.39	0.42	-0.37	0.39	0.39	0.39	0.56	0.38	0.56	0.69	0.55	0.26	0.41	0.38		0.73	0.39	0.75	0.22	0.45	0.5	0.26	0.34	0.35
Other Liab	0.81	0.58	0.65	0.82	-0.79	0.77	0.71	0.79	0.85	0.79	0.88	0.85	0.82	0.73	0.66	0.79	0.73		0.81	0.85	0.73	0.51	0.67	0.72	0.52	0.8
Net Tangible Assets	0.98	0.67	0.76	0.99	-0.98	0.94	0.86	0.98	0.92	0.98	0.94	0.82	0.91	0.84	0.77	0.99	0.39	0.81		0.77	0.92	0.56	0.74	0.86	0.62	0.93
Property Plant And Equipment Net	0.84	0.81	0.84	0.82	-0.8	0.84	0.81	0.8	0.93	0.8	0.77	0.87	0.83	0.59	0.85	0.8	0.75	0.85	0.77		0.64	0.66	0.74	0.56	0.78	0.71
Current Deferred Revenue	0.87	0.46	0.61	0.89	-0.91	0.81	0.74	0.88	0.79	0.88	0.89	0.68	0.82	0.97	0.61	0.88	0.22	0.73	0.92	0.64		0.4	0.51	0.97	0.4	0.99
Non Currrent Assets Other	0.64	0.65	0.67	0.63	-0.6	0.66	0.68	0.62	0.7	0.62	0.58	0.69	0.77	0.34	0.68	0.62	0.45	0.51	0.56	0.66	0.4		0.5	0.31	0.69	0.42
Other Assets	0.8	0.75	0.73	0.79	-0.77	0.85	0.71	0.8	0.84	0.78	0.61	0.88	0.67	0.36	0.74	0.78	0.5	0.67	0.74	0.74	0.51	0.5		0.44	0.74	0.54
Net Receivables	0.77	0.28	0.43	0.81	-0.83	0.69	0.59	0.79	0.69	0.78	0.88	0.64	0.76	0.98	0.44	0.79	0.26	0.72	0.86	0.56	0.97	0.31	0.44		0.21	0.97
Good Will	0.75	0.98	0.95	0.71	-0.7	0.83	0.85	0.72	0.82	0.73	0.46	0.69	0.63	0.24	0.95	0.72	0.34	0.52	0.62	0.78	0.4	0.69	0.74	0.21		0.42
Common Stock Total Equity	0.88	0.49	0.63	0.9	-0.92	0.82	0.75	0.89	0.82	0.89	0.93	0.73	0.85	0.97	0.64	0.89	0.35	0.8	0.93	0.71	0.99	0.42	0.54	0.97	0.42

Click cells to compare fundamentals

Cronos Account Relationship Matchups

Cronos fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.1B	1.9B	1.4B	1.2B	1.1B	809.1M
Other Current Liab	297.2M	183.3M	37.1M	18.5M	16.5M	15.7M
Total Current Liabilities	332.9M	206.8M	54.4M	68.1M	41.4M	75.2M
Total Stockholder Equity	1.7B	1.7B	1.3B	1.1B	1.1B	730.8M
Net Debt	(1.2B)	(1.1B)	(877.2M)	(760.8M)	(666.7M)	(633.4M)
Retained Earnings	1.1B	1.1B	659.4M	490.7M	416.7M	373.6M
Accounts Payable	35.3M	19.3M	11.1M	11.2M	12.1M	9.9M
Cash	1.2B	1.1B	887.0M	764.6M	669.3M	463.4M
Non Current Assets Total	520.4M	553.5M	318.0M	252.9M	206.8M	209.9M
Cash And Short Term Investments	1.5B	1.3B	1.0B	877.7M	861.5M	557.5M
Common Stock Shares Outstanding	172.3M	342.8M	351.6M	370.4M	381.0M	233.2M
Liabilities And Stockholders Equity	2.1B	1.9B	1.4B	1.2B	1.1B	809.1M
Non Current Liabilities Total	8.5M	10.7M	9.1M	3.9M	2.6M	4.5M
Other Current Assets	12.6M	12.3M	9.0M	13.6M	5.4M	6.2M
Other Stockholder Equity	23.2M	34.6M	32.5M	42.7M	48.4M	50.9M
Total Liab	341.4M	217.5M	63.5M	72.0M	44.0M	79.6M
Total Current Assets	1.6B	1.4B	1.1B	960.2M	933.3M	599.3M
Short Long Term Debt Total	7.1M	9.8M	9.8M	3.9M	2.6M	2.4M
Other Liab	1.8M	2.2M	2.0M	1.4M	1.6M	1.5M
Net Tangible Assets	1.5B	1.5B	1.3B	1.1B	1.3B	683.9M
Property Plant And Equipment Net	168.4M	197.4M	83.0M	62.8M	60.8M	83.2M
Non Currrent Assets Other	64.4M	87.7M	100K	72.5M	45K	42.8K
Other Assets	64.4M	87.7M	80.7M	193K	222.0K	210.9K
Net Receivables	16.5M	26.0M	33.3M	31.3M	35.9M	37.7M
Good Will	214.8M	179.5M	1.1M	1.0M	1.1M	1.0M
Common Stock Total Equity	66.4M	165.6M	561.2M	569.3M	654.6M	687.4M
Inventory	38.0M	44.0M	32.8M	37.6M	30.5M	23.1M
Long Term Investments	557K	19.2M	135.2M	89.7M	54.7M	35.9M
Property Plant And Equipment Gross	168.4M	197.4M	83.0M	207.2M	200.6M	114.5M
Accumulated Other Comprehensive Income	27.8M	43.0M	49.9M	(797K)	20.7M	15.9M
Short Term Debt	427K	1.3M	2.7M	1.3M	994K	944.3K
Intangible Assets	72.3M	69.7M	18.1M	26.7M	21.1M	26.0M
Common Stock	561.2M	569.3M	595.5M	611.3M	613.7M	355.3M
Property Plant Equipment	166.5M	197.4M	83.0M	62.8M	72.3M	85.3M
Capital Surpluse	23.2M	34.6M	32.5M	42.7M	49.1M	51.5M
Cash And Equivalents	1.2B	1.1B	887.0M	764.6M	879.3M	622.7M
Net Invested Capital	1.7B	1.7B	1.3B	1.1B	1.1B	1.1B

When determining whether Cronos Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cronos' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cronos Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cronos Group Stock:

How To Invest In Cronos

Details

Is Cronos Stock a good investment?

Details

What is Cronos' Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Please note, there is a significant difference between Cronos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cronos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cronos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cronos Pb Ratio vs Price To Sales Ratio Analysis

Pb Ratio vs Price To Sales Ratio

Pb Ratio vs Price To Sales Ratio Correlation Analysis

Correlation Coefficient

Pb Ratio

Price To Sales Ratio

Cronos fundamental ratios Correlations

Cronos Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cronos fundamental ratios Accounts

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Cash	+ 1.0	Total Stockholder Equity

Cash	- 1.0	Net Debt
Total Current Assets	- 0.99	Net Debt
Cash And Short Term Investments	- 0.99	Net Debt
Net Debt	- 0.99	Total Stockholder Equity
Net Debt	- 0.99	Total Assets
Net Tangible Assets	- 0.98	Net Debt